Rickman john m d (66 risultati)
Editore: Garden City, N.Y. Doubleday & Company, Inc. 1957, 1957
- Brossura
Da: Black and Read Books, Music & Games, Arvada, CO, U.S.A.Black and Read Books, Music & Games
Contatta il venditoreVenditore con 3 stelleCondizione: Usato
EUR 1,44
EUR 5,24 spedizioneSpedito in U.S.A.Quantità: 1 disponibili
Reprint edition. Mild shelf wear to the wraps. Rubbing to the head / tail of the spine. Top / bottom edge of the pages / free endpaper have light stamps. The internal pages are clean and the binding is sound. A solid copy.
Editore: Leonard & Vierginal Woolf at the Hagarth Press, 1926
- Rilegato
Da: 2Vbooks, Derwood, MD, U.S.A.2Vbooks
Contatta il venditoreVenditore con 5 stelleCondizione: Usato
EUR 22,41
EUR 4,37 spedizioneSpedito in U.S.A.Quantità: 1 disponibili
Hard cover. Condizione: Very good. No dust jacket. No. 11. 471 p. No previous owner's name but a few pencil notes on black page. Clean, tight pages. No bent corners. No remainder mark. eb 102.
Editore: Doubleday Anchor
- Brossura
Da: Kennys Bookstore, Olney, MD, U.S.A.Kennys Bookstore
Contatta il venditoreVenditore con 5 stelleCondizione: Usato - Molto buono
EUR 17,46
EUR 9,19 spedizioneSpedito in U.S.A.Quantità: 2 disponibili
Condizione: Very Good. 1957. Paperback. Vintage paperback. Good clean condition with some minor reader wear. . . . . Books ship from the US and Ireland.
Editore: Doubleday Anchor, 1957
- Brossura
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandaKennys Bookshop and Art Galleries Ltd.
Contatta il venditoreVenditore con 5 stelleCondizione: Usato - Molto buono
EUR 21,54
EUR 10,50 spedizioneSpedito da Irlanda a U.S.A.Quantità: 2 disponibili
Condizione: Very Good. 1957. Paperback. Vintage paperback. Good clean condition with some minor reader wear. . . . .
Lingua: Inglese
Editore: Cham, Springer., 2018
Serie: Advances in Experimental Medicine and Biology, Libro 490 di 490. Libro 490 di 490 - Advances in Experimental Medicine and Biology
- Rilegato
Da: Universitätsbuchhandlung Herta Hold GmbH, Berlin, GermaniaUniversitätsbuchhandlung Herta Hold GmbH
Contatta il venditoreVenditore con 4 stelleCondizione: Usato
EUR 27,00
EUR 30,00 spedizioneSpedito da Germania a U.S.A.Quantità: 7 disponibili
xlii, 669 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Lavail, Matthew M. (EDT); Anderson, Robert E. (EDT); Grimm, Christian (EDT); Hollyfield, Joe (EDT)
- Brossura
Da: GreatBookPricesUK, Woodford Green, Regno UnitoGreatBookPricesUK
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 227,35
EUR 17,52 spedizioneSpedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Condizione: New.
Lingua: Inglese
Editore: Springer, 2016
Serie: Advances in Experimental Medicine and Biology, Libro 21 di 490. Libro 21 di 490 - Advances in Experimental Medicine and Biology
- Brossura
Da: Phatpocket Limited, Waltham Abbey, HERTS, Regno UnitoPhatpocket Limited
Contatta il venditoreVenditore con 5 stelleCondizione: Usato - Buono
EUR 239,86
EUR 12,42 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Condizione: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Lavail, Matthew M. (EDT); Anderson, Robert E. (EDT); Grimm, Christian (EDT); Hollyfield, Joe (EDT)
- Brossura
Da: GreatBookPricesUK, Woodford Green, Regno UnitoGreatBookPricesUK
Contatta il venditoreVenditore con 5 stelleCondizione: Usato - Come nuovo
EUR 257,85
EUR 17,52 spedizioneSpedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Condizione: As New. Unread book in perfect condition.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Lavail, Matthew M. (EDT); Anderson, Robert E. (EDT); Grimm, Christian (EDT); Hollyfield, Joe (EDT)
- Brossura
Da: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 309,14
EUR 2,31 spedizioneSpedito in U.S.A.Quantità: Più di 20 disponibili
Condizione: New.
Lingua: Inglese
Editore: Springer, 2014
Serie: Advances in Experimental Medicine and Biology, Libro 21 di 490. Libro 21 di 490 - Advances in Experimental Medicine and Biology
- Rilegato
Da: Ria Christie Collections, Uxbridge, Regno UnitoRia Christie Collections
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 313,58
EUR 13,99 spedizioneSpedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Condizione: New. In.
- Brossura
Da: Ria Christie Collections, Uxbridge, Regno UnitoRia Christie Collections
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 313,58
EUR 13,99 spedizioneSpedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Condizione: New. In.
Lingua: Inglese
Editore: Springer, 2018
Serie: Advances in Experimental Medicine and Biology, Libro 490 di 490. Libro 490 di 490 - Advances in Experimental Medicine and Biology
- Rilegato
Da: Ria Christie Collections, Uxbridge, Regno UnitoRia Christie Collections
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 313,58
EUR 13,99 spedizioneSpedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Condizione: New. In.
Lingua: Inglese
Editore: Springer International Publishing, 2018
Serie: Advances in Experimental Medicine and Biology, Libro 490 di 490. Libro 490 di 490 - Advances in Experimental Medicine and Biology
- Rilegato
Da: moluna, Greven, Germaniamoluna
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 267,86
EUR 48,99 spedizioneSpedito da Germania a U.S.A.Quantità: Più di 20 disponibili
Gebunden. Condizione: New.
- Brossura
Da: moluna, Greven, Germaniamoluna
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 267,86
EUR 48,99 spedizioneSpedito da Germania a U.S.A.Quantità: Più di 20 disponibili
Condizione: New.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Lavail, Matthew M. (EDT); Anderson, Robert E. (EDT); Grimm, Christian (EDT); Hollyfield, Joe (EDT)
- Brossura
Da: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contatta il venditoreVenditore con 5 stelleCondizione: Usato - Come nuovo
EUR 349,84
EUR 2,31 spedizioneSpedito in U.S.A.Quantità: Più di 20 disponibili
Condizione: As New. Unread book in perfect condition.
Altre immagini- Brossura
Da: preigu, Osnabrück, Germaniapreigu
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 274,60
EUR 70,00 spedizioneSpedito da Germania a U.S.A.Quantità: 5 disponibili
Taschenbuch. Condizione: Neu. Retinal Degenerative Diseases | Mechanisms and Experimental Therapy | John D. Ash (u. a.) | Taschenbuch | Advances in Experimental Medicine and Biology | xlii | Englisch | 2019 | Springer | EAN 9783030092214 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelbe…rg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Altre immaginiLingua: Inglese
Editore: Springer, 2016
Serie: Advances in Experimental Medicine and Biology, Libro 21 di 490. Libro 21 di 490 - Advances in Experimental Medicine and Biology
- Brossura
Da: preigu, Osnabrück, Germaniapreigu
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 274,60
EUR 70,00 spedizioneSpedito da Germania a U.S.A.Quantità: 5 disponibili
Taschenbuch. Condizione: Neu. Retinal Degenerative Diseases | Mechanisms and Experimental Therapy | John D. Ash (u. a.) | Taschenbuch | lxi | Englisch | 2016 | Springer | EAN 9781493952762 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | An…bieter: preigu.
Lingua: Inglese
Editore: Springer, 2021
Serie: Advances in Experimental Medicine and Biology, Libro 396 di 490. Libro 396 di 490 - Advances in Experimental Medicine and Biology
- Brossura
Da: Ria Christie Collections, Uxbridge, Regno UnitoRia Christie Collections
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 350,52
EUR 13,99 spedizioneSpedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Condizione: New. In.
Lingua: Inglese
Editore: Springer, 2019
Serie: Advances in Experimental Medicine and Biology, Libro 396 di 490. Libro 396 di 490 - Advances in Experimental Medicine and Biology
- Rilegato
Da: Ria Christie Collections, Uxbridge, Regno UnitoRia Christie Collections
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 350,52
EUR 13,99 spedizioneSpedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Condizione: New. In.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Grimm, Christian (EDT); Anderson, Robert E. (EDT); Ash, John D. (EDT); Lavail, Matthew M. (EDT)
Lingua: Inglese
Editore: Springer, 2019
Serie: Advances in Experimental Medicine and Biology, Libro 396 di 490. Libro 396 di 490 - Advances in Experimental Medicine and Biology
- Rilegato
Da: GreatBookPricesUK, Woodford Green, Regno UnitoGreatBookPricesUK
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 350,51
EUR 17,52 spedizioneSpedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Condizione: New.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Grimm, Christian (EDT); Anderson, Robert E. (EDT); Ash, John D. (EDT); Lavail, Matthew M. (EDT)
Lingua: Inglese
Editore: Springer, 2019
Serie: Advances in Experimental Medicine and Biology, Libro 396 di 490. Libro 396 di 490 - Advances in Experimental Medicine and Biology
- Rilegato
Da: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 373,06
EUR 2,31 spedizioneSpedito in U.S.A.Quantità: Più di 20 disponibili
Condizione: New.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Grimm, Christian (EDT); Anderson, Robert E. (EDT); Ash, John D. (EDT); Lavail, Matthew M. (EDT)
Lingua: Inglese
Editore: Springer, 2019
Serie: Advances in Experimental Medicine and Biology, Libro 396 di 490. Libro 396 di 490 - Advances in Experimental Medicine and Biology
- Rilegato
Da: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contatta il venditoreVenditore con 5 stelleCondizione: Usato - Come nuovo
EUR 390,60
EUR 2,31 spedizioneSpedito in U.S.A.Quantità: Più di 20 disponibili
Condizione: As New. Unread book in perfect condition.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Grimm, Christian (EDT); Anderson, Robert E. (EDT); Ash, John D. (EDT); Lavail, Matthew M. (EDT)
Lingua: Inglese
Editore: Springer, 2019
Serie: Advances in Experimental Medicine and Biology, Libro 396 di 490. Libro 396 di 490 - Advances in Experimental Medicine and Biology
- Rilegato
Da: GreatBookPricesUK, Woodford Green, Regno UnitoGreatBookPricesUK
Contatta il venditoreVenditore con 5 stelleCondizione: Usato - Come nuovo
EUR 386,61
EUR 17,52 spedizioneSpedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Condizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: Springer, 2019
Serie: Advances in Experimental Medicine and Biology, Libro 396 di 490. Libro 396 di 490 - Advances in Experimental Medicine and Biology
- Rilegato
Da: California Books, Miami, FL, U.S.A.California Books
Contatta il venditoreVenditore con 4 stelleCondizione: Nuovo
EUR 402,16
Spedizione gratuitaSpedito in U.S.A.Quantità: Più di 20 disponibili
Condizione: New.
Lingua: Inglese
Editore: Springer, Springer, 2014
Serie: Advances in Experimental Medicine and Biology, Libro 21 di 490. Libro 21 di 490 - Advances in Experimental Medicine and Biology
- Rilegato
Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 325,30
EUR 67,66 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibili
Buch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited retinal de…generations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases andneurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume.
Lingua: Inglese
Editore: Springer, 2021
Serie: Advances in Experimental Medicine and Biology, Libro 396 di 490. Libro 396 di 490 - Advances in Experimental Medicine and Biology
- Brossura
Da: Buchpark, Trebbin, GermaniaBuchpark
Contatta il venditoreVenditore con 5 stelleCondizione: Usato
EUR 292,19
EUR 105,00 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibili
Condizione: Hervorragend. Zustand: Hervorragend | Seiten: 616 | Sprache: Englisch | Produktart: Bücher | This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of… inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the ¿best¿ and ¿most important¿ meetings in the field. The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes,cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations were described, there will be many new topics that either are in their infancy or did not exist at the time of the last RD Symposium, RD2016. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2016 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.
Lingua: Inglese
Editore: Springer, Humana, 2016
Serie: Advances in Experimental Medicine and Biology, Libro 21 di 490. Libro 21 di 490 - Advances in Experimental Medicine and Biology
- Brossura
Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 333,77
EUR 66,85 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibili
Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited ret…inal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases andneurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume.
- Brossura
Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 333,77
EUR 65,30 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibili
Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium wi…ll focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2014. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2018 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume.
Lingua: Inglese
Editore: Springer, 2021
Serie: Advances in Experimental Medicine and Biology, Libro 396 di 490. Libro 396 di 490 - Advances in Experimental Medicine and Biology
- Brossura
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandaKennys Bookshop and Art Galleries Ltd.
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 433,63
EUR 10,50 spedizioneSpedito da Irlanda a U.S.A.Quantità: 15 disponibili
Condizione: New.
Lingua: Inglese
Editore: Springer International Publishing, Springer Nature Switzerland, 2021
Serie: Advances in Experimental Medicine and Biology, Libro 396 di 490. Libro 396 di 490 - Advances in Experimental Medicine and Biology
- Brossura
Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 374,49
EUR 65,71 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibili
Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of inherited retinal deg…enerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field. The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes,cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations were described, there will be many new topics that either are in their infancy or did not exist at the time of the last RD Symposium, RD2016. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2016 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.
